Endolysin B: A new archetype in M. tuberculosis treatment
A. Griego, B. Antinori, A. Spitaleri, I. Muzzolini, S. Muzzioli, L. Calo, G. Moschetti, M. Genta, E. Scarpa, V. De Matteis, R. Miggiano, S. Ricagno, L. Rizzello
This study demonstrates that Ms6LysB can impair M. tuberculosis growth and retain lytic properties when internalized by macrophages, suggesting its potential as a new therapeutic strategy.
bioRxiv · Dec 5, 2023 · PreprintMicrobiology